Vessel occluder advanceable over an infusion catheter
The microvalve treatment system with a microcatheter and movable occluder addresses inefficiencies in systemic treatments by enhancing drug concentration and reducing reflux, enabling precise infusion into target tissues.
Patent Information
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- TRISALUS LIFE SCIENCES INC
- Filing Date
- 2024-12-30
- Publication Date
- 2026-07-16
AI Technical Summary
Existing systemic treatments for diseases like cancer and diabetes face challenges due to insufficient drug concentration at target tissues, leading to inefficacy and systemic side effects, while standard end-hole catheters lack control over infusion and can cause reflux to non-target areas.
A microvalve treatment system comprising a microcatheter and a longitudinally movable microvalve vessel occluder that can be advanced over the catheter to control infusion and occlude blood vessels, allowing targeted delivery of therapeutic agents to specific locations within the vasculature.
Enhances drug concentration at target tissues by reducing reflux and improving delivery efficiency, minimizing systemic side effects, and enabling precise infusion into smaller vessels.
Smart Images

Figure 00000000_0000_ABST